Clinical Trials

Breast Cancer Trials

Learn More About Our Breast Cancer Trials

  • 1 S1207 Show More

    S1207 – Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer.

    1. WHAT TYPE OF CANCER? WHAT STAGE?
    Early Stage Breast Cancer (Stage I, II, and III)

    2. WHO IS ELIGIBLE?
    Women who are ER/PR+ but Her2-

    3. HOW WILL I BE TREATED?
    Women may also receive Everolimus (an mTOR inhibitor)

    For Physicians: More information about this specific trial at clinicaltrials.gov

  • 2 A5481082 Show More

    A5481082 Palbociclib in Hormone Receptor Postive Advanced Breast Cancer: A Prospective Multi center Non-Interventional Study

    1. WHAT TYPE OF CANCER? WHAT STAGE?
    Triple Negative Breast Cancer

    2. WHO IS ELIGIBLE?
    Women with Inoperable or Metastatic disease

    3. HOW WILL I BE TREATED?
    Women may also receive palcociclib (Ibrance), which is used to treat ER+ breast cancer

    For Physicians: More information about this specific trial at clinicaltrials.gov

EJGH Trials Send us an Inquiry

Click here